Sung Ji Nam

Contact Us
Sung Ji Nam is a Director and Life Science and Diagnostic Tools Analyst at BTIG. She provides comprehensive coverage of the life science and diagnostic tools sector. Prior to BTIG, Ms. Nam was a Senior Analyst within Equity Research at Avondale Partners. She held similar roles at Cantor Fitzgerald and Gleacher & Company, where she was named an All-America Research Team Rising Star by Institutional Investor in 2011. Ms. Nam began her career in equity research at JP Morgan, covering life science tools, diagnostics, small to mid-cap medical technology and pharmaceutical services companies. Previously, she was a Senior Program Officer of Science, Higher Education and Healthcare at the Gordon and Betty Moore Foundation. Earlier in her career, Ms. Nam was a Financial Analyst within the Healthcare Corporate Finance Group at Robertson Stephens. She holds a BA in chemistry and an MBA, both from Harvard University.

Coverage Area

Company Ticker
Fulgent Genetics FLGT
Bruker Corporation BRKR
Castle Biosciences, Inc. CSTL
Fluidigm Corporation FLDM
GenMark Diagnostics, Inc. GNMK
Illumina, Inc. ILMN
Luminex Corporation LMNX
Myriad Genetics, Inc. MYGN
Oxford Immunotec Global PLC OXFD
Quotient Ltd. QTNT
Quanterix Corporation QTRX
Thermo Fisher Scientific, Inc. TMO
Veracyte, Inc. VCYT
Waters Corporation WAT
Centogene CNTG
Guardant Health GH
Genetron Holdings GTH